| Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase–positive lymphoma patients C Gambacorti Passerini, F Farina, A Stasia, S Redaelli, M Ceccon, ... Journal of the National Cancer Institute 106 (2), djt378, 2014 | 304 | 2014 |
| Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead V Minard-Colin, L Brugières, A Reiter, MS Cairo, TG Gross, ... Journal of Clinical Oncology 33 (27), 2963, 2015 | 268 | 2015 |
| Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150 M Ghisi, A Corradin, K Basso, C Frasson, V Serafin, S Mukherjee, ... Blood, The Journal of the American Society of Hematology 117 (26), 7053-7062, 2011 | 257 | 2011 |
| Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis L Mussolin, C Damm-Welk, M Pillon, M Zimmermann, G Franceschetto, ... Leukemia 27 (2), 416-422, 2013 | 131 | 2013 |
| Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma L Mussolin, M Pillon, ES d'Amore, N Santoro, A Lombardi, F Fagioli, ... Leukemia 19 (9), 1643-1647, 2005 | 128 | 2005 |
| MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas C Schneider, M Setty, AB Holmes, RL Maute, CS Leslie, L Mussolin, ... Proceedings of the National Academy of Sciences 111 (22), 8185-8190, 2014 | 99 | 2014 |
| Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK–positive anaplastic large-cell lymphoma C Damm-Welk, L Mussolin, M Zimmermann, M Pillon, W Klapper, ... Blood, The Journal of the American Society of Hematology 123 (3), 334-337, 2014 | 98 | 2014 |
| Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib C Gambacorti-Passerini, L Mussolin, L Brugieres New England Journal of Medicine 374 (1), 95-96, 2016 | 86 | 2016 |
| Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma S Cannella, A Santoro, G Bruno, M Pillon, L Mussolin, G Mangili, ... Cancer 109 (12), 2566-2571, 2007 | 68 | 2007 |
| Plasma cell-free DNA in paediatric lymphomas L Mussolin, R Burnelli, M Pillon, E Carraro, P Farruggia, A Todesco, ... Journal of Cancer 4 (4), 323, 2013 | 60 | 2013 |
| Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosis L Mussolin, M Pillon, ESG d'Amore, V Conter, M Piglione, LL Nigro, ... Journal of Clinical Oncology 29 (13), 1779-1784, 2011 | 56 | 2011 |
| T‐cell lymphoblastic lymphoma shows differences and similarities with T‐cell acute lymphoblastic leukemia by genomic and gene expression analyses K Basso, L Mussolin, A Lettieri, M Brahmachary, WK Lim, A Califano, ... Genes, Chromosomes and Cancer 50 (12), 1063-1075, 2011 | 55 | 2011 |
| Long‐term results of AIEOP LNH‐92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology M Pillon, M Piglione, A Garaventa, V Conter, M Giuliano, G Arcamone, ... Pediatric blood & cancer 53 (6), 953-959, 2009 | 54 | 2009 |
| Results of AIEOP LNH‐97 protocol for the treatment of anaplastic large cell lymphoma of childhood M Pillon, F Gregucci, A Lombardi, N Santoro, M Piglione, A Sala, ... Pediatric blood & cancer 59 (5), 828-833, 2012 | 52 | 2012 |
| Prognostic factors in childhood anaplastic large cell lymphoma: long term results of the international ALCL99 trial L Mussolin, MC Le Deley, E Carraro, C Damm-Welk, A Attarbaschi, ... Cancers 12 (10), 2747, 2020 | 51 | 2020 |
| Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood L Mussolin, M Pillon, V Conter, M Piglione, L Lo Nigro, P Pierani, ... Journal of clinical oncology 25 (33), 5254-5261, 2007 | 51 | 2007 |
| Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL L Mussolin, P Bonvini, K Ait-Tahar, M Pillon, G Tridello, S Buffardi, ... Leukemia 23 (2), 400-402, 2009 | 50 | 2009 |
| Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t (8; 14)(q24; q32) L Mussolin, K Basso, M Pillon, ES d'Amore, A Lombardi, L Luzzatto, ... Leukemia 17 (3), 585-589, 2003 | 48 | 2003 |
| Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with the AIEOP LNH‐97 protocol M Pillon, L Mussolin, E Carraro, V Conter, M Aricò, L Vinti, A Garaventa, ... British journal of haematology 175 (3), 467-475, 2016 | 41 | 2016 |
| Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience L Mussolin, B Buldini, F Lovisa, E Carraro, S Disarò, LL Nigro, ... Pediatric blood & cancer 62 (11), 1906-1913, 2015 | 39 | 2015 |
